Joanne Liutkus

5.7k total citations
12 papers, 336 citations indexed

About

Joanne Liutkus is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Joanne Liutkus has authored 12 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Joanne Liutkus's work include Diabetes Treatment and Management (10 papers), Metabolism, Diabetes, and Cancer (8 papers) and Diabetes Management and Research (5 papers). Joanne Liutkus is often cited by papers focused on Diabetes Treatment and Management (10 papers), Metabolism, Diabetes, and Cancer (8 papers) and Diabetes Management and Research (5 papers). Joanne Liutkus collaborates with scholars based in Canada, Denmark and United States. Joanne Liutkus's co-authors include Stephen D. Walter, Lauren E. Griffith, Gordon Guyatt, Paul Norwood, Michael Trautmann, Katarı́na Rašlová, Trine Vang Skjøth, Jacob Råstam, Priscilla Hollander and Justin Northrup and has published in prestigious journals such as Diabetes, Diabetes Obesity and Metabolism and Clinical Therapeutics.

In The Last Decade

Joanne Liutkus

11 papers receiving 321 citations

Peers

Countries citing papers authored by Joanne Liutkus

Since Specialization

Citations

This map shows the geographic impact of Joanne Liutkus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne Liutkus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne Liutkus more than expected).

Fields of papers citing papers by Joanne Liutkus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne Liutkus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne Liutkus. The network helps show where Joanne Liutkus may publish in the future.

Co-authorship network of co-authors of Joanne Liutkus

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne Liutkus. A scholar is included among the top collaborators of Joanne Liutkus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne Liutkus. Joanne Liutkus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial 2023 ·Diabetes Obesity and Metabolism ·Natalia McInnes, Stephanie Hall, Heather Lochnan, Stewart B. Harris, Zubin Punthakee, Ronald J. Sigal, Irene Hramiak, Mohammed Azharuddin, Joanne Liutkus, Jean‐François Yale, Farah Sultan, Ada Smith, (unknown), Diana Sherifali, Yan Yun Liu, Hertzel C. Gerstein, (unknown)	8
2	Real-world use of once-weekly semaglutide in patients with type 2 diabetes: pooled analysis of data from four SURE studies by baseline characteristic subgroups 2022 ·BMJ Open Diabetes Research & Care ·Jean‐François Yale, (unknown), Andrei‐Mircea Catarig, Sergiu‐Bogdan Catrina, A. J. Clark, Neda Rajamand Ekberg, (unknown), (unknown), Søren Tang Knudsen, Joanne Liutkus, Thozhukat Sathyapalan, Bernd Schultes, Gottfried Rudofsky	33
3	Evaluating the Effectiveness of Switching to Insulin Degludec from Other Basal Insulins in a Real-World Canadian Population with Type 1 or Type 2 Diabetes: The CAN-TREAT Study 2021 ·Diabetes Therapy ·Stewart B. Harris, Olubukola Ajala, (unknown), Joanne Liutkus, (unknown), (unknown), (unknown)	1
4	Use of once‐weekly semaglutide in patients with type 2 diabetes in routine clinical practice: Results from the SURE C anada multicentre, prospective, observational study 2021 ·Diabetes Obesity and Metabolism ·Jean‐François Yale, Andrei‐Mircea Catarig, Katrine Grau, Stewart B. Harris, Agnieszka Klimek‐Abercrombie, Rémi Rabasa‐Lhoret, (unknown), Vincent Woo, Joanne Liutkus	31
5	677-P: Remission of Type 2 Diabetes following Intensive Treatment with Insulin Glargine, Lixisenatide, Metformin, and Lifestyle Approaches: Results of a Multicenter Randomized Controlled Trial 2021 ·Diabetes ·Natalia McInnes, Stephanie Hall, Heather Lochnan, Stewart B. Harris, Zubin Punthakee, Ronald J. Sigal, Irene Hramiak, Mohammed Azharuddin, Joanne Liutkus, Jean‐François Yale, Farah Sultan, Ada Smith, (unknown), Diana Sherifali, Yan Yun Liu, Hertzel C. Gerstein, (unknown)	0
6	Efficacy and Safety of Once-Weekly Semaglutide vs. Once-Daily Insulin Glargine in Insulin-Naïve Subjects with Type 2 Diabetes (SUSTAIN 4) 2016 ·Canadian Journal of Diabetes ·Joanne Liutkus, Vanita R. Aroda, Stephen C. Bain, Bertrand Cariou, Milivoj Piletič, (unknown), Everton Rowe, (unknown)	2
7	Liraglutide 3.0 mg Reduces Body Weight and Improves Health-Related Quality of Life (HRQoL) in Overweight or Obese Adults without Diabetes: The SCALE Obesity and Prediabetes Randomized, Double-Blind, Placebo-Controlled, 56-Week Trial 2015 ·Canadian Journal of Diabetes ·Joanne Liutkus, Ken Fujioka, Arne Astrup, Frank L. Greenway, Alfredo Halpern, Michel Krempf, David C.W. Lau, Carel W. le Roux, Rafael Violante Ortíz, John Wilding, Michael Lyng Wolden, Damir Boras, Xavier Pi‐Sunyer	4
8	Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With a Thiazolidinedione Alone or in Combination With Metformin for 2 Years 2012 ·Clinical Therapeutics ·Paul Norwood, Joanne Liutkus, Harry Haber, Ella Pintilei, Marilyn K. Boardman, Michael Trautmann	22
9	A placebo‐controlled trial of exenatide twice‐daily added to thiazolidinediones alone or in combination with metformin 2010 ·Diabetes Obesity and Metabolism ·Joanne Liutkus, Juan Rosas Guzmán, Paul Norwood, Lavinia Pop, Justin Northrup, Dachuang Cao, Michael Trautmann	68
10	Efficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin: the TRANSITION randomized controlled trial 2010 ·Diabetes Obesity and Metabolism ·Priscilla Hollander, Katarı́na Rašlová, Trine Vang Skjøth, Jacob Råstam, Joanne Liutkus	55
11	Attitudes toward the use of gender-inclusive language among residency trainees. The McMaster Residency Training Program Directors. 1997 ·PubMed ·Gordon Guyatt, (unknown), Lauren E. Griffith, Stephen D. Walter, (unknown), Joanne Liutkus	4
12	Residents' experiences of abuse, discrimination and sexual harassment during residency training. McMaster University Residency Training Programs. 1996 ·PubMed ·(unknown), Joanne Liutkus, (unknown), Lauren E. Griffith, Gordon Guyatt, Stephen D. Walter	108

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact